(Q43696461)

English

High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-li

scientific article published in July 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486821%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486821%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

E Dailly

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486821%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

L Thomas

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486821%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M F Kergueris

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486821%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

P Jolliet

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486821%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Bourin

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486821%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486821%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Journal of Chromatography B: Biomedical Sciences and Applications

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486821%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

758

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486821%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486821%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

129-135

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486821%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A 24-week open-label phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extractio

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous determination of the five HIV-protease inhibitors: amprenavir, indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by solid-phase extraction and column liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents amprenavir, nelfinavir, ritonavir, saquinavir, delavirdine and efavirenz in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of ritonavir, a new HIV protease inhibitor, in biological samples using reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900117-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0378-4347(01)00117-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486821%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486821%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43696461&oldid=2102646551"